C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2009
11/25/2009	EP2121647A1 Organic thin film transistors comprising thienyl oligomers and their use as gaseous phase sensors
11/25/2009	EP2121583A1 Heteroaryl-substituted serine amides
11/25/2009	EP2120575A1 Sphingosine-1 -phosphate receptor agonist and antagonist compounds
11/25/2009	EP1638924B1 Pesticidally active ketone and oxime derivatives
11/25/2009	CN201351149Y Preparation device of Alpha-acetyl-Gamma-butyrolactone
11/25/2009	CN101589033A Method for the one-step synthesis of 2-methyltetrahydrofuran from furfural and a catalyst
11/25/2009	CN101586136A Method of high-efficiency pretreatment on biomass
11/25/2009	CN101584691A Compounds effecting glucokinase
11/25/2009	CN100562519C Method for producing furfural by cleaning hydrolysis of biomass
11/25/2009	CN100562516C Beta-amyloid protein production/secretion inhibitors
11/24/2009	US7622612 Tricyclic derivatives and their use
11/24/2009	US7622598 2,4-dihydroxybenzaldehyde or 2,4-dihydroxybenzoic acid derivatives having alkyl side chains, or ether derivatives thereof; e.g. 5-chloro-2,4-dihydroxy-6-methyl-3-(1-hydroxy-3,7-dimethyloct-6-en-1-yl)benzaldehyde; effective at a lower concentration than ascofuranone and has high safety; trypanosomiasis
11/24/2009	US7622500 Antiparasitic agents
11/24/2009	US7622464 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists
11/24/2009	CA2552786C Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/24/2009	CA2451124C Method for the preparation of escitalopram
11/24/2009	CA2418794C Calcium receptor antagonists
11/24/2009	CA2385882C Tyrosine derivatives
11/24/2009	CA2385859C 2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
11/19/2009	WO2009139593A2 Method for preparing chiral intermediates for preparation of hmg-coa reductase inhibitors
11/19/2009	WO2009139438A1 Process for production of optically active carboxylic acid
11/19/2009	US20090287004 Method of Converting a Polyol to an Olefin
11/19/2009	US20090287003 Process for the production of intermediates for making prostaglandin derivatives such as latanaprost, travaprost, and bimatoprost
11/19/2009	US20090286999 Catalyst system for preparing carboxylic acids and/or carboxylic anhydrides
11/19/2009	US20090286873 AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure
11/19/2009	US20090286776 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/19/2009	US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/18/2009	EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/18/2009	EP1409441B1 Indane compounds with negative dielectric anisotropy
11/18/2009	CN201347416Y Condenser system for phthalic anhydride production
11/18/2009	CN101583593A Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
11/18/2009	CN101580503A Green synthesis method of furane derivative
11/18/2009	CN101580498A Green synthesis method of furane derivative
11/18/2009	CN101580465A Substituted phenyl keto enols as pesticides and herbicides
11/18/2009	CN101580451A Novel organic electroluminescent compound and electroluminescent device using the same
11/17/2009	US7619101 Hydrogenation of (S)-4-fluoromethyldihydrofuran-2-one by way of a catalytic asymmetric hydrogenation in the presence of a chiral catalyst of a ruthenium or a rhodium complex catalyst containing a chiral diphosphine ligand; coupling with pyrido[2,1-a]isoquinoline derivatives; deprotection of the amine
11/17/2009	US7619099 Reacting n-butane gas with oxygen gas in the presence ofa vanadium phosphorus oxide catalyst; continuously adding a trialkyl phosphite or phosphate while heating at 400-440 degree C and maintaining a and maintaining a maximum temperature of gases 480 degrees C.,; acrylic acid by-product <1.5%
11/17/2009	US7619098 Distillation purification ; discharging low boiling compounds
11/17/2009	US7618918 Gas phase oxidation of o-xylene or naphthalene using an inert support havinga layer catalytically active composition of titanium oxide with the following properties:a BET surface area of >15 m2/g and a primary crystal size of > 210 angstrom; tube bundle reactors cooled by heat carrier melt
11/17/2009	CA2522051C Diamine derivative, production process therefor and antioxidant
11/17/2009	CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/12/2009	WO2009137500A1 6-substituted benzofuran compounds to treat infection with hepatitis c virus
11/12/2009	WO2009137493A1 2-substituted benzofuran compounds to treat infection with hepatitis c virus
11/12/2009	WO2009137412A1 Therapeutic compounds
11/12/2009	WO2009137411A1 Therapeutic compounds
11/12/2009	WO2009135979A1 Method for obtaining zaragozic acid and derivatives thereof
11/12/2009	WO2009135978A1 Method for obtaining cinatrins c3 and c1
11/12/2009	WO2009115874A3 Novel heterocyclic compounds, pharmaceutical compositions containing them and processes for their preparation
11/12/2009	WO2009069132A3 Novel reverse transcriptase inhibitors
11/12/2009	US20090281338 Processes for the preparation and purification of hydroxymethylfuraldehyde derivatives
11/12/2009	US20090281337 Pyridazine compound and use thereof
11/12/2009	US20090281336 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
11/12/2009	US20090281321 Exo- and diastereo- selective syntheses of himbacine analogs
11/12/2009	US20090281301 Manufacturing Process of 2' ,2' - Difluoronucleoside and Intermediate
11/12/2009	US20090281176 Process for the synthesis of ramelteon and its intermediates
11/12/2009	US20090281131 Diebenzofuran derivatives as inhibitors of pde-4 and pde-10
11/11/2009	EP2116527A1 Oxime compound, photosensitive composition, color filter, method for production of the color filter, and liquid crystal display element
11/11/2009	EP2114910A1 A novel crystalline mycophenolate sodium polymorph and processes to manufacture same
11/11/2009	EP2114849A1 Method of purifying dianhydrides
11/11/2009	EP1742908B1 Non-nucleoside reverse transcriptase inhibitors
11/11/2009	EP1406870B1 Taxol enhancer compounds
11/11/2009	EP1339673B1 Malonamide and malonamic ester derivatives with antithrombotic activity, their preparation and their use
11/11/2009	CN101578261A Heteroaryl-substituted serine amides
11/11/2009	CN101578260A Insecticidal compounds
11/11/2009	CN101575325A Technique for preparing super fine vitamin C powder
11/11/2009	CN101575324A Preparation method for extracting anticancer valid-position medicine SHIKEMOXIN from sweetsop
11/11/2009	CN101575312A Substituted phenyl keto enols as pesticides and herbicides
11/11/2009	CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof
11/11/2009	CN100558720C Liquid crystal compound with diphenylene-oxide structure and composition thereof
11/11/2009	CN100558719C Two-set benzoic anhydride reaction device employing public air feeding system and operation method thereof
11/11/2009	CN100558712C Therapeutic molecules and methods-1
11/11/2009	CN100558697C Cycloalkyl inhibitors of potassium channel function
11/11/2009	CN100558354C Triptolide lactone ring derivatives as immunomodulators and anticancer agents
11/10/2009	US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009	US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009	US7615514 Pre-emergence and post-emergence selective herbicidal compositions comprising an active compound combination consisting of substituted arylsulphonylaminocarbonyl-triazolinones and/or salts thereof and at least one compound which improves crop plant compatibility
11/10/2009	US7615513 Use of a multi-layer catalyst for producing phthalic anhydride
11/10/2009	CA2417401C Benzofuran derivatives and their use as antibacterial agents
11/10/2009	CA2408292C Method for the preparation of citalopram
11/05/2009	WO2009134631A1 Method of conversion of carbohydrate polymers to value-added chemical products
11/05/2009	WO2009133950A1 Method for producing vinyl ether compound
11/05/2009	WO2009133917A1 Anthracene derivative and organic electroluminescent element using the same
11/05/2009	WO2009133021A1 Paper sizing additives, their preparation process, and their use
11/05/2009	US20090275761 Catalytic Preparation of Cyclic Carboxylic Esters
11/05/2009	US20090275753 Ortho-substituted aniline derivative and antioxidant drug
11/05/2009	US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/05/2009	US20090275651 Alcanoic Acid Amides Substituted by Saturated O-Heterocycles
11/05/2009	US20090274984 Carboxyl-containing lactone compound, polymer, resist composition, and patterning process
11/05/2009	US20090274733 Pharmaceutical preparation containing copolyvidone
11/05/2009	US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/05/2009	CA2722977A1 Paper sizing additives, their preparation process, and their use
11/04/2009	EP2113502A1 Hydrazyde type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
11/04/2009	EP2113258A1 Aurone derivative-containing composition for diagnosis
11/04/2009	EP1532130B1 Process for the production of an immunosuppressant
11/04/2009	EP1253152B1 Method of converting functional group through halogen-metal exchange reaction
11/04/2009	CN101573346A Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
11/03/2009	US7612105 3-arylphenyl sulfide derivative and insecticide and miticide
11/03/2009	US7612092 Nitrogen-containing aromatic derivatives
11/03/2009	CA2565660C Ortho substituted aryl or heteroaryl amide compounds
11/03/2009	CA2497074C Substituted spirocyclic ketoenols

1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 472